Table 3

Significant peptide peaks differentiating BTC from healthy volunteers
Mass (m/z) Peak area Peak area Fold- change Wilcoxon test AUROC
BTC +/- SD H +/- SD (BTC vs H) P value
887.2 5.2+/-7.1 1.8+/-0.5 2.82 0.000691 0.79
1263.7 21.8+/-9.9 47.4+/-22.7 0.46 <0.000001 0.91
1350.8 48.3+/-25.7 117.4+/-62.3 0.41 <0.000001 0.92
2082.1 10.0+/-3.4 24.4+/-20.5 0.41 0.0000364 0.86
2210.3 10.9+/-3.8 38.2+/-31.6 0.29 <0.000001 0.92
2554.5 24.8+/-17.8 57.3+/-20.6 0.43 <0.000001 0.91
2903.3 24.1+/-10.0 11.5+/-2.5 2.09 <0.000001 0.97
5805.0 33.0+/-30.9 6.7+/-1.6 4.93 <0.000001 0.96

*Wilcoxon test P values were corrected for multiple testing using the Benjamini-Hochberg adjustment. Area under the Receiver Operating Characteristic curve.

Sandanayake et al.

Sandanayake et al. BMC Clinical Pathology 2014 14:7   doi:10.1186/1472-6890-14-7

Open Data